NF-κB signaling blockade can inhibit in vitro and in vivo expression of VEGF, IL-8, and MMP-9, resulting in decreased neoplastic angiogenesis [182] and metastasis of pancreatic cancer (Figure 4) [183]. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.